Stay updated with breaking news from Benjamin Jackson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In his latest research note, analyst Benjamin Jackson confirms his positive recommendation. The broker Jefferies is keeping its Buy rating. The target price continues to be set at EUR 16.
Unclear prospects continue to dampen Evotec's share price on Wednesday after the latest figures. The pharmaceutical drug researcher and developer recorded a weaker start to the year, but above all the...
Benjamin Jackson from Jefferies retains his positive opinion on the stock with a Buy rating. The target price has been revised downwards and is now set at EUR 16 as compared to EUR 28 previously.
Analyst firm Jefferies has lowered its target price for Evotec from 28 to 16 euros, but left its rating at Buy. The drug discovery company's outlook remains vague ahead of the start of the new CEO in...
WEST GARDINER - Jacqueline Elizabeth “Beth” Theberge, 75, passed away at her home on April 29, 2024. She was born on ...